Case Study: Phase II Psoriasis Summer Enrollment

A leading global pharmaceutical company with a focus on dermatology selected Novella Clinical to conduct two large, Phase II psoriasis studies involving a combined 700 patients at 40 sites. Novella was challenged to achieve the sponsor’s goal of randomizing 300 scalp/body psoriasis and 400 body-only psoriasis patients in an 18-week period, from early May through the end of August, a difficult time of year for enrollment of this condition. Novella’s strategic patient recruitment process reduced enrollment timelines, enrolling all patients weeks ahead of schedule.